TP53 mutations have been associated with better engraftment of EGFR-mutant lung adenocarcinomas in PDX models previously50 and we speculate that, in LUAD tumors, higher chromosomal instability might represent an advantage in adapting to novel environments. This evidence concerns the gene TP53 and lung adenocarcinoma.